Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Healthy Habits in Middle Age Increase Cardiovascular Disease-Free Longevity

By HospiMedica International staff writers
Posted on 21 Nov 2012
A new study reveals that maintenance of optimal risk factor levels during middle age is associated with substantially longer years lived free of cardiovascular disease (CVD).

Researchers at the Northwestern University Feinberg School of Medicine (Chicago, IL, USA; www.feinberg.northwestern.edu) reviewed the pooled survival analysis of 905,115 person-years of data from 1964 through 2008 from five community-based cohorts. More...
All participants were free of CVD at baseline for risk factor data--blood pressure (BP), total cholesterol (TC), diabetes, and smoking status--and total CVD outcome data. The researchers calculated lifetime risk estimates of total CVD by index age (45, 55, 65, 75 years), risk factor strata, and then estimated years lived free of CVD across risk factor strata.

The results showed that the overall lifetime risk for total cardiovascular disease from ages 45 to 95 was 60% for men and 55% for women. The lifetime risk of CVD was 30% at age 45, and at age 75 the risk increased to 52% for women and 54% for men. But those with optimal risk factor profiles at age 45 lived about 14 years longer free of total CVD, compared with those with at least two major risk factors in middle age. Total CVD risk for men was greater than that for women across all ages, but staying active in middle age and meeting standards to keep risk factors low significantly improved event-free survival. The study was published online on November 5, 2012, in the Journal of the American Medical Association (JAMA).

“The lifetime risk estimates for total cardiovascular disease were high for all individuals, even those with optimal risk factors in middle age,” concluded lead author John Wilkins, MD, MS, and colleagues. “Maintenance of optimal risk factors through ages 45, 55, and 65 years may not guarantee a life free from total CVD, but it increases the probability that more years will be lived free of CVD.”

For the study, the researchers pooled survival data from the Framingham Heart Study, the Framingham Offspring Study, the Atherosclerosis Risk in Communities Study, the Chicago Heart Association Detection Project in Industry Study, and the Cardiovascular Health Study. All five studies were funded by the US National Heart, Lung, and Blood Institute (Bethesda, MD, USA;).

Related Links:

Northwestern University Feinberg School of Medicine
National Heart, Lung, and Blood Institute



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.